Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Findings from papers in eBioMedicine advance development of IAVI’s single-dose Lassa fever vaccine candidate 

April 16, 2025

Nonhuman primates protected from Lassa fever; high-resolution images show how vaccine-induced antibodies bind to the viral surface.

Read more

Features

IAVI at the World Vaccine Congress Washington 2025

April 16, 2025

IAVI leaders to guide urgent dialogue on R&D for vaccines and antibodies in a dynamic global health landscape.

Read more

Features

IAVI and Japan’s premier global health organization pilot Human Resource Development Program

April 1, 2025

Visiting scientist Taka Funaki learned about IAVI’s discovery, regulatory, manufacturing, and clinical trial expertise in the program’s first two-week exchange.

Read more

Features

Meet the women at the helm of IAVI’s Lassa program

March 6, 2025

IAVI commemorates International Women’s Day 2025.

Read more

Features

IAVI announces termination of the PEPFAR-funded ADVANCE program and staff reductions

February 27, 2025

ADVANCE produced a legacy of achievement in the search for an HIV vaccine.

Read more

Features

Fast facts about IAVI’s contributions to the 2025 Sudan virus disease outbreak in Uganda

February 26, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including the orthoebolavirus Sudan virus, since 2018.

Read more

Features

Meet the Scientist: Zandile Ciko on IAVI’s community engagement work

February 26, 2025

Zandile Ciko, a community engagement manager with IAVI in Cape Town, South Africa, discusses her work with IAVI’s community engagement team.

Read more

Features

IAVI opens new Vaccine Design and Development Laboratory space in Jersey City, NJ

February 14, 2025

Leading vaccine research and development lab now housed in an upgraded, fit-for-purpose life sciences facility.

Read more